| Financial Year |
March 31 2023 |
| Monetary Funds |
286,716,746.28 |
| Held-for-trading Financial Assets |
389,000,000.00 |
| Notes Receivable |
46,376,578.12 |
| Accounts Receivable |
209,336,261.44 |
| Advances to Suppliers |
7,363,593.02 |
| Other Receivables |
3,465,341.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,354,055.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,541,152.85 |
| Total Current Assets |
1,171,468,055.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,248,189.77 |
| Investment Properties |
2,201,513.02 |
| Fixed Assetes |
113,316,134.85 |
| Under-construction Projects |
582,300.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,015,000.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
672,000.00 |
| Deferred Income Tax Assets |
5,361,335.16 |
| Other Non-Current Assets |
651,575.40 |
| Sub-Total of Non-Current Assets |
190,048,049.70 |
| Total Assets |
1,361,516,104.83 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,040,000.00 |
| Accounts Payable |
63,049,501.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,878,291.32 |
| Taxes Payable |
5,003,971.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,118,504.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,764,474.31 |
| Sub-Total of Current Liabilities |
109,427,621.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,968,438.37 |
| Total Liabilities |
125,396,060.01 |
| Paid-In Capital(Or Share Stock) |
206,006,025.00 |
| Capital Surplus |
439,381,315.90 |
| Surplus Reserve |
75,489,293.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
503,110,958.43 |
| Minority Stockholder's Interest |
8,761,315.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,227,358,729.46 |
| Owner's Equity（Stockholder's Equity） |
1,236,120,044.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,361,516,104.83 |
